Login / Signup

The Impact of Beta Blockers on Survival in Heart Transplant Recipients: Insights from the Zabrze HTx Registry.

Grzegorz M KubiakRadosław KwiecińskiAgnieszka CiarkaAndrzej TukiendorfPiotr PrzybyłowskiTomasz HrapkowiczMichał O Zembala
Published in: Cardiology research and practice (2020)
The use of BBs in our cohort of patients after HTx was not associated with survival benefits.
Keyphrases
  • end stage renal disease
  • newly diagnosed
  • ejection fraction
  • chronic kidney disease
  • heart failure
  • peritoneal dialysis
  • free survival
  • atrial fibrillation
  • patient reported